Skip to main content
Erschienen in: Neuroradiology 3/2015

01.03.2015 | Diagnostic Neuroradiology

Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy

verfasst von: D. J. She, Z. Xing, Z. Zeng, X. Y. Shang, D. R. Cao

Erschienen in: Neuroradiology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Hemangioblastomas and pilocytic astrocytomas (PAs) present similar imaging features on conventional MR imaging, making differential diagnosis a challenge. The purpose of this study was to evaluate the usefulness of dynamic susceptibility-weighted contrast-enhanced perfusion-weighted imaging (DSC-PWI) and proton MR spectroscopic imaging in the differentiation of hemangioblastomas and PAs.

Methods

A 3.0-T MR imaging unit was used to perform DSC-PWI and conventional MR imaging on 14 patients with hemangioblastomas and 22 patients with PAs. Four patients with hemangioblastomas and 10 PA patients also underwent proton MR spectroscopy. Parameters of relative peak height (rPH) and relative percentage of signal intensity recovery (rPSR) were acquired by DSC-PWI and variables of N-acetylaspasrtate (NAA)/creatine (Cr), choline (Cho)/Cr, and lactate-lipid (Lac-Lip)/Cr by MR spectroscopy. The sensitivity, specificity, and the area under the receiver operating characteristic curve of all analyzed parameters at respective cutoff values were determined.

Results

Higher rPH but lower rPSR values were detected in hemangioblastomas compared to PAs. The NAA/Cr ratio was significantly lower in hemangioblastomas compared with PAs. The threshold values ≥3.2 for rPH provide sensitivity, specificity, positive predictive values, and negative predictive values of 85.7, 95.5, 92.3, and 91.3 %, respectively, for differentiating hemangioblastomas from PAs. The optimal threshold values were ≤0.9 for rPSR and ≤1.5 for NAA/Cr ratios in tumor.

Conclusion

Significantly higher rPH and lower NAA/Cr were seen in patients with hemangioblastomas when compared with PA patients, suggesting that DSC-PWI and proton MR spectroscopy are helpful in the characterization and differentiation of these two types of tumors.
Literatur
2.
Zurück zum Zitat Catapano D, Muscarella LA, Guarnieri V, Zelante L, D’Angelo VA, D’Agruma L (2005) Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery 56(6):1215–1221, discussion 1221CrossRefPubMed Catapano D, Muscarella LA, Guarnieri V, Zelante L, D’Angelo VA, D’Agruma L (2005) Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery 56(6):1215–1221, discussion 1221CrossRefPubMed
3.
Zurück zum Zitat Koeller KK, Rushing EJ (2004) From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics : Rev Publ Radiol Soc N Am Inc 24(6):1693–1708. doi:10.1148/rg.246045146 CrossRef Koeller KK, Rushing EJ (2004) From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics : Rev Publ Radiol Soc N Am Inc 24(6):1693–1708. doi:10.​1148/​rg.​246045146 CrossRef
5.
Zurück zum Zitat Padhi S, Sarangi R, Challa S, Bussary P, Panigrahi MK, Purohit AK (2011) A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease. J Clin Neurosci Off J Neurosurg Soc Australasia 18(7):939–944. doi:10.1016/j.jocn.2010.12.050 Padhi S, Sarangi R, Challa S, Bussary P, Panigrahi MK, Purohit AK (2011) A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease. J Clin Neurosci Off J Neurosurg Soc Australasia 18(7):939–944. doi:10.​1016/​j.​jocn.​2010.​12.​050
6.
Zurück zum Zitat Erridge SC, Hart MG, Kerr GR, Smith C, McNamara S, Grant R, Gregor A, Whittle IR (2011) Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort. J Neurooncol 104(3):789–800. doi:10.1007/s11060-011-0546-0 CrossRefPubMed Erridge SC, Hart MG, Kerr GR, Smith C, McNamara S, Grant R, Gregor A, Whittle IR (2011) Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort. J Neurooncol 104(3):789–800. doi:10.​1007/​s11060-011-0546-0 CrossRefPubMed
7.
Zurück zum Zitat Bladowska J, Zimny A, Guzinski M, Halon A, Tabakow P, Czyz M, Czapiga B, Jarmundowicz W, Sasiadek MJ (2013) Usefulness of perfusion weighted magnetic resonance imaging with signal-intensity curves analysis in the differential diagnosis of sellar and parasellar tumors: preliminary report. Eur J Radiol 82(8):1292–1298. doi:10.1016/j.ejrad.2013.01.033 CrossRefPubMed Bladowska J, Zimny A, Guzinski M, Halon A, Tabakow P, Czyz M, Czapiga B, Jarmundowicz W, Sasiadek MJ (2013) Usefulness of perfusion weighted magnetic resonance imaging with signal-intensity curves analysis in the differential diagnosis of sellar and parasellar tumors: preliminary report. Eur J Radiol 82(8):1292–1298. doi:10.​1016/​j.​ejrad.​2013.​01.​033 CrossRefPubMed
8.
Zurück zum Zitat Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32(6):1004–1010. doi:10.3174/ajnr.A2441 CrossRefPubMed Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32(6):1004–1010. doi:10.​3174/​ajnr.​A2441 CrossRefPubMed
9.
Zurück zum Zitat Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP (2007) Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 28(6):1078–1084. doi:10.3174/ajnr.A0484 CrossRefPubMed Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP (2007) Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 28(6):1078–1084. doi:10.​3174/​ajnr.​A0484 CrossRefPubMed
10.
Zurück zum Zitat Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K (1999) Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood–brain-barrier. Magn Reson Imaging 17(1):21–27CrossRefPubMed Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K (1999) Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood–brain-barrier. Magn Reson Imaging 17(1):21–27CrossRefPubMed
11.
Zurück zum Zitat Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 253(2):486–496. doi:10.1148/radiol.2532090007 CrossRefPubMedCentralPubMed Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 253(2):486–496. doi:10.​1148/​radiol.​2532090007 CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Lupo JM, Cha S, Chang SM, Nelson SJ (2005) Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 26(6):1446–1454PubMed Lupo JM, Cha S, Chang SM, Nelson SJ (2005) Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 26(6):1446–1454PubMed
13.
Zurück zum Zitat Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y, Takahashi M (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44(8):656–666. doi:10.1007/s00234-002-0816-9 CrossRefPubMed Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y, Takahashi M (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44(8):656–666. doi:10.​1007/​s00234-002-0816-9 CrossRefPubMed
14.
Zurück zum Zitat Orphanidou-Vlachou E, Auer D, Brundler MA, Davies NP, Jaspan T, MacPherson L, Natarajan K, Sun Y, Arvanitis TN, Grundy RG, Peet AC (2013) (1)H magnetic resonance spectroscopy in the diagnosis of paediatric low grade brain tumours. Eur J Radiol 82(6):e295–e301. doi:10.1016/j.ejrad.2013.01.030 CrossRefPubMed Orphanidou-Vlachou E, Auer D, Brundler MA, Davies NP, Jaspan T, MacPherson L, Natarajan K, Sun Y, Arvanitis TN, Grundy RG, Peet AC (2013) (1)H magnetic resonance spectroscopy in the diagnosis of paediatric low grade brain tumours. Eur J Radiol 82(6):e295–e301. doi:10.​1016/​j.​ejrad.​2013.​01.​030 CrossRefPubMed
15.
Zurück zum Zitat Bing F, Kremer S, Lamalle L, Chabardes S, Ashraf A, Pasquier B, Le Bas JF, Krainik A, Grand S (2009) Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings. J Neuroradiol J Neuroradiol 36(2):82–87. doi:10.1016/j.neurad.2008.09.002 CrossRef Bing F, Kremer S, Lamalle L, Chabardes S, Ashraf A, Pasquier B, Le Bas JF, Krainik A, Grand S (2009) Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings. J Neuroradiol J Neuroradiol 36(2):82–87. doi:10.​1016/​j.​neurad.​2008.​09.​002 CrossRef
16.
Zurück zum Zitat Grand SD, Kremer S, Tropres IM, Hoffmann DM, Chabardes SJ, Lefournier V, Berger FR, Pasteris C, Krainik A, Pasquier BM, Peoch M, Le Bas JF (2007) Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology 49(7):545–550. doi:10.1007/s00234-006-0204-y CrossRefPubMed Grand SD, Kremer S, Tropres IM, Hoffmann DM, Chabardes SJ, Lefournier V, Berger FR, Pasteris C, Krainik A, Pasquier BM, Peoch M, Le Bas JF (2007) Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology 49(7):545–550. doi:10.​1007/​s00234-006-0204-y CrossRefPubMed
17.
Zurück zum Zitat Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS Jr (1998) Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19(3):535–540PubMed Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS Jr (1998) Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19(3):535–540PubMed
18.
Zurück zum Zitat Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223(1):11–29CrossRefPubMed Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223(1):11–29CrossRefPubMed
19.
Zurück zum Zitat Kumar VA, Knopp EA, Zagzag D (2010) Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results. J Comput Assist Tomogr 34(6):825–829. doi:10.1097/RCT.0b013e3181ef77e2 CrossRefPubMed Kumar VA, Knopp EA, Zagzag D (2010) Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results. J Comput Assist Tomogr 34(6):825–829. doi:10.​1097/​RCT.​0b013e3181ef77e2​ CrossRefPubMed
20.
Zurück zum Zitat Cuccurullo L, Prudente ME, Maffia S, Accardo M (2009) An ultrastructural study of the histogenesis of haemangioblastoma. Pathologica 101(1):1–5PubMed Cuccurullo L, Prudente ME, Maffia S, Accardo M (2009) An ultrastructural study of the histogenesis of haemangioblastoma. Pathologica 101(1):1–5PubMed
22.
Zurück zum Zitat Uematsu H, Maeda M, Sadato N, Ishimori Y, Matsuda T, Koshimoto Y, Kimura H, Yamada H, Kawamura Y, Takeuchi H, Yonekura Y, Itoh H (2002) Measurement of the vascularity and vascular leakage of gliomas by double-echo dynamic magnetic resonance imaging: a preliminary study. Investig Radiol 37(10):571–576. doi:10.1097/01.RLI.0000028483.51109.29 CrossRef Uematsu H, Maeda M, Sadato N, Ishimori Y, Matsuda T, Koshimoto Y, Kimura H, Yamada H, Kawamura Y, Takeuchi H, Yonekura Y, Itoh H (2002) Measurement of the vascularity and vascular leakage of gliomas by double-echo dynamic magnetic resonance imaging: a preliminary study. Investig Radiol 37(10):571–576. doi:10.​1097/​01.​RLI.​0000028483.​51109.​29 CrossRef
24.
Zurück zum Zitat de Fatima Vasco Aragao M, Law M, Batista de Almeida D, Fatterpekar G, Delman B, Bader AS, Pelaez M, Fowkes M, Vieira de Mello R, Moraes Valenca M (2014) Comparison of perfusion, diffusion, and MR spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas. AJNR Am J Neuroradiol 35(8):1495–1502. doi:10.3174/ajnr.A3905 CrossRefPubMed de Fatima Vasco Aragao M, Law M, Batista de Almeida D, Fatterpekar G, Delman B, Bader AS, Pelaez M, Fowkes M, Vieira de Mello R, Moraes Valenca M (2014) Comparison of perfusion, diffusion, and MR spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas. AJNR Am J Neuroradiol 35(8):1495–1502. doi:10.​3174/​ajnr.​A3905 CrossRefPubMed
25.
Zurück zum Zitat Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25(5):746–755PubMed Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25(5):746–755PubMed
26.
Zurück zum Zitat Kuesel AC, Briere KM, Halliday WC, Sutherland GR, Donnelly SM, Smith IC (1996) Mobile lipid accumulation in necrotic tissue of high grade astrocytomas. Anticancer Res 16(3B):1485–1489PubMed Kuesel AC, Briere KM, Halliday WC, Sutherland GR, Donnelly SM, Smith IC (1996) Mobile lipid accumulation in necrotic tissue of high grade astrocytomas. Anticancer Res 16(3B):1485–1489PubMed
28.
Zurück zum Zitat Isobe T, Yamamoto T, Akutsu H, Anno I, Shiigai M, Zaboronok A, Masumoto T, Takano S, Matsumura A (2010) Proton magnetic resonance spectroscopy findings of hemangioblastoma. Jpn J Radiol 28(4):318–321. doi:10.1007/s11604-010-0421-5 CrossRefPubMed Isobe T, Yamamoto T, Akutsu H, Anno I, Shiigai M, Zaboronok A, Masumoto T, Takano S, Matsumura A (2010) Proton magnetic resonance spectroscopy findings of hemangioblastoma. Jpn J Radiol 28(4):318–321. doi:10.​1007/​s11604-010-0421-5 CrossRefPubMed
Metadaten
Titel
Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy
verfasst von
D. J. She
Z. Xing
Z. Zeng
X. Y. Shang
D. R. Cao
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 3/2015
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-014-1475-3

Weitere Artikel der Ausgabe 3/2015

Neuroradiology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.